<DOC>
	<DOCNO>NCT01238497</DOCNO>
	<brief_summary>This registry expand upon exist data set , identify patient characteristic indicator related complication clinical benefit patient symptomatic severe calcific degenerative aortic stenosis undergo treatment commercially available Edwards SAPIEN XT™ Valve , delivery device .</brief_summary>
	<brief_title>SOURCE XT REGISTRY</brief_title>
	<detailed_description>Consecutive patient data collect discharge , 30 day 12 month post-implant . Subsets patient may undergo additional follow-up .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>The SAPIEN XT™ THV indicate use patient symptomatic aortic stenosis require TAVI high risk operative mortality , `` nonoperable '' Nonvalvular congenital aortic stenosis Preexisting prosthetic heart valve Aortic position noncalcified aortic valve Severe ( &gt; 3+ ) mitral insufficiency aortic regurgitation &gt; 3+ Active bacterial endocarditis active infection Severe ventricular dysfunction ejection fraction &lt; 20 % Coronary artery diseaserelated unstable angina Inability tolerate anticoagulation / antiplatelet therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>SAPIEN XT™</keyword>
	<keyword>Transfemoral</keyword>
	<keyword>NovaFlex</keyword>
	<keyword>NovaFlex+</keyword>
	<keyword>NF</keyword>
	<keyword>NF+</keyword>
	<keyword>Transapical</keyword>
	<keyword>Transaortic</keyword>
	<keyword>Ascendra2</keyword>
	<keyword>Ascendra+</keyword>
	<keyword>Asc+</keyword>
	<keyword>aortic stenosis</keyword>
	<keyword>aortic valve</keyword>
	<keyword>Transcatheter Heart Valve</keyword>
	<keyword>THV</keyword>
</DOC>